Connection Between Kidney Cancer and Tobacco Use: A Closer Look
In the world of cancer, kidney cancer ranks as the 14th most common, with the highest incidence found in Western countries [1]. Renal cancer, as it is commonly known, can manifest in various forms, including renal cell carcinomas (RCCs), transitional cell carcinomas (TCCs), and Wilms' tumours. This article will focus on TCCs, a less-discussed but significant subtype of kidney cancer [1].
TCCs originate in the tissue lining of the kidneys, particularly in the urinary tract. Unlike RCCs, which develop in the filtering tubules of the kidney, TCCs arise specifically in the renal pelvis, the part of the kidney where urine collects [1].
Factors influencing the incidence of kidney cancers, including TCC, align with known kidney cancer risk factors such as smoking, obesity, hypertension, genetic predispositions, and chronic kidney disease [2].
Smoking, a global health issue, is a major contributor to the onset of many cancers, including kidney cancer. The risk increases with longer duration and intensity of smoking [2]. Obesity, another significant factor, is associated with higher kidney cancer risk due to related metabolic and hormonal changes [2].
Hypertension (high blood pressure) is linked to increased kidney cancer incidence [2]. Genetic conditions, such as von Hippel-Lindau disease and Birt-Hippel-Dube syndrome, increase an individual's susceptibility to kidney cancer [2][3]. Prior radiation, especially in women treated for reproductive cancers, may also elevate kidney cancer risk [2].
Chronic kidney disease and long-term dialysis are known to increase the risk for kidney cancers, including potentially TCC, due to ongoing renal damage and regeneration cycles [2].
Specific trends in TCC incidence are less detailed in the current sources, but because TCC originates in the urinary tract lining, exposures linked to urothelial carcinomas—such as smoking and certain chemical exposures—likely influence TCC incidence. Common symptoms include blood in the urine (hematuria), which is a hallmark for TCC and other urothelial cancers [4].
Current trends in kidney cancer overall emphasize advances in precision medicine, including biomarker-driven personalized treatments and the investigation of the gut microbiome’s influence on cancer outcomes; however, these advances focus largely on RCC rather than TCC specifically [1][3].
In sum, while recent research and treatment innovation mainly focus on RCC, the incidence of TCC in the kidney is influenced by established risk factors shared with kidney and urothrial cancers, especially smoking, obesity, hypertension, genetic predispositions, and chronic kidney injury. Emerging precision medicine approaches have not yet specifically targeted TCC of the kidney but are advancing the broader field of kidney cancer care [1][2][3][4].
References:
[1] American Cancer Society. (2021). What Are the Key Statistics About Kidney Cancer? Retrieved from https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html
[2] National Cancer Institute. (2021). Who Is At Risk? Retrieved from https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq/risk-factors
[3] Mayo Clinic. (2021). Transitional Cell Carcinoma of the Kidney. Retrieved from https://www.mayoclinic.org/diseases-conditions/transitional-cell-carcinoma-of-the-kidney/symptoms-causes/syc-20353711
[4] American Society of Clinical Oncology. (2021). What Are the Symptoms of Kidney Cancer? Retrieved from https://www.cancer.net/cancer-types/kidney-cancer/symptoms-and-signs
- TCCs, a lesser-discussed subtype of kidney cancer, originate in the tissue lining of the kidneys, particularly in the urinary tract.
- Unlike RCCs, TCCs develop specifically in the renal pelvis, the part of the kidney where urine collects.
- Factors influencing the incidence of kidney cancers, including TCC, are similar to those of kidney cancer risk factors such as smoking, obesity, hypertension, genetic predispositions, and chronic kidney disease.
- Smoking, a global health issue, is a major contributor to the onset of many cancers, including kidney cancer.
- Obesity, another significant factor, is associated with higher kidney cancer risk due to related metabolic and hormonal changes.
- Hypertension (high blood pressure) is linked to increased kidney cancer incidence.
- Genetic conditions, such as von Hippel-Lindau disease and Birt-Hippel-Dube syndrome, increase an individual’s susceptibility to kidney cancer.
- Prior radiation, especially in women treated for reproductive cancers, may also elevate kidney cancer risk.
- Chronic kidney disease and long-term dialysis are known to increase the risk for kidney cancers, including TCC, due to ongoing renal damage and regeneration cycles.
- Specific trends in TCC incidence are less detailed, but because TCC originates in the urinary tract lining, exposures linked to urothelial carcinomas—such as smoking and certain chemical exposures—likely influence TCC incidence.
- Common symptoms of TCC include blood in the urine (hematuria), which is a hallmark for TCC and other urothelial cancers.
- Precision medicine advances, including biomarker-driven personalized treatments and the investigation of the gut microbiome’s influence on cancer outcomes, are mainly focused on RCC rather than TCC specifically.
- In the world of health and wellness, cancer is a serious medical condition that affects many individuals, and TCC is a subtype that requires attention and research.
- Personal finance and lifestyle choices play a role in cancer prevention, as smoking and obesity contribute to increased cancer risk.
- From sports-analysis to social media, it's crucial to maintain an awareness of health issues like TCC, as overall health impacts mental health, lifestyle, and personal finances, and influences fashion and beauty choices, entertainment, and even hobbies such as golf or football.